Novacyt (FR:ALNOV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Novacyt, an international specialist in clinical diagnostics, reported its monthly liquidity agreement update, revealing that Invest Securities traded a total of 63,796 ordinary shares at prices ranging from €0.52 to €0.62 in July 2024. The company’s total number of ordinary shares now stands at 70,626,248, with 53,064 held in treasury. This financial activity underlines Novacyt’s ongoing market maneuvers and may be of interest to shareholders for their stake calculations and notifications.
For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.
